CDK4 and breast carcinoma: As cells enter the G1 phase, CDK4/6 complexes phosphorylate TFEB, leading to its nuclear export and inactivation (Figure 1 and Figure 6) [21], and CDK4/6 inhibition increases lysosome biogenesis in breast cancer cells [161,162].